Lixte Biotechnology Holdings, Inc.

Lixte Biotechnology Holdings, Inc. (Lixte) is a research based cancer therapeutics and diagnostics company engaged in development of improved treatments of human cancers. The company is currently developing new chemotherapy drugs by targeting molecular abnormalities of human cancers. It develops new treatments for brain cancers in adults like glioblastoma multiforme and other cancer forms in child like neuroblastoma and medulloblastoma. Lixte has established a cooperative research and development agreement with National Institute of Neurological Disorders and Stroke of the National Institutes of Health for development of its anti-cancer treatments. The company is headquartered at East Seta in New York, the US.

Street: 
248 Route 25A No. 2
City: 
East Setauket
Postcode: 
11733
Federal State : 
United States
WebSite: 
www.lixte.com
Fax: 
1-928-9825050

Company Index Score

Current Index Score Historical Index Score
  • Lixte Biotechnology Holdings, Inc. currently scores 50 % in the index.
  • Lixte Biotechnology Holdings, Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Lixte Biotechnology Holdings, Inc. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets